Literature DB >> 16099425

Regulation of Bcl-3 through interaction with the Lck tyrosine kinase.

Yujie Zhao1, Aravind Ramakrishnan, Kyoung-Eun Kim, Arnold B Rabson.   

Abstract

bcl-3 is a protooncogene which undergoes chromosomal translocation in a subset of chronic B-cell lymphocytic leukemia cells. Bcl-3 is a unique IkappaB family protein that regulates transcription of a number of NF-kappaB target genes through interactions with NF-kappaB dimers. Based on previous studies, suggesting that Bcl-3 interacts with the Fyn tyrosine kinase in platelets, we investigated possible interactions of Bcl-3 with Lck, a related tyrosine kinase important in lymphoid cells. Protein-protein interactions between Bcl-3 and the Lck tyrosine kinase were identified both in vitro and in vivo. Lck enhanced Bcl-3-mediated activation of a p52/Bcl-3-responsive promoter in reporter gene assays independent of its tyrosine kinase activity, but requiring the Lck SH3 protein interaction domain. These studies suggest that Bcl-3 might participate in oncogenic pathways involving Lck.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099425     DOI: 10.1016/j.bbrc.2005.07.162

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets.

Authors:  Andrew S Weyrich; Melvin M Denis; Hansjorg Schwertz; Neal D Tolley; Jason Foulks; Eliott Spencer; Larry W Kraiss; Kurt H Albertine; Thomas M McIntyre; Guy A Zimmerman
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

2.  Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50.

Authors:  Patricia E Collins; Patrick A Kiely; Ruaidhrí J Carmody
Journal:  J Biol Chem       Date:  2014-01-23       Impact factor: 5.157

Review 3.  Role of Bcl-3 in solid tumors.

Authors:  Vilma Maldonado; Jorge Melendez-Zajgla
Journal:  Mol Cancer       Date:  2011-12-23       Impact factor: 27.401

4.  Transgenic Bcl-3 slows T cell proliferation.

Authors:  Michael F J Bassetti; Janice White; John W Kappler; Philippa Marrack
Journal:  Int Immunol       Date:  2009-02-10       Impact factor: 4.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.